Stockreport

COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results

COSCIENS Biopharma Inc.  (CSCI) 
PDF                 Data from pivotal DETECT-Trial evaluating macimorelin for the diagnosis of childhood-onset growth hormone deficiency expected in Q3 2024 Company ended [Read more]